Androgenetic Alopecia Market Size Expected to Reach US$ 10,717.6 Million by 2033 | IMARC Group

The newly published report by IMARC Group, titled "Androgenetic Alopecia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the androgenetic alopecia market size. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.

How big is the market for androgenetic alopecia?

According to IMARC Group, in 2022, the total value of the seven major markets (7MM) for androgenetic alopecia market amounted to US$ 5,877.8 Million. Looking forward, these markets are anticipated to reach US$ 10,717.6 Million by 2033, at a growth rate (CAGR) of 5.6% from 2023-2033.

Request for a Sample Report: https://www.imarcgroup.com/androgenetic-alopecia-market/requestsample

What is androgenetic alopecia?

Androgenetic alopecia represents a hair loss condition that largely affects the top and front of the scalp. It is distinguished by hair follicles that gradually decrease in size. This patterned hair loss is commonly known as non-scarring follicle loss and has a particular pattern in both males and females. Androgenetic alopecia originates just above the temples and at the vertex area of the scalp in men. A border of hair remains at the sides and back of the head as it proceeds. This condition causes widespread thinning without hairline recession in females, as it does in males, and seldom leads to overall hair loss. Men with androgenetic alopecia can be interpreted by their appearance, which includes symptoms and indications of male pattern baldness. In contrast, diagnosis in women typically entails a complicated sequence of testing. Additional tests can be performed using trichoscopy, and a biopsy may also be required to rule out other reasons for hair loss.

Explore the Full Report with Table of Contents: https://www.imarcgroup.com/androgenetic-alopecia-market

What are the key drivers and trends in the androgenetic alopecia market?

The escalating prevalence of severe follicle loss and damage, owing to unhealthy eating habits, sedentary lifestyles, and rising stress levels, is among the primary factors driving the androgenetic alopecia market. In addition to this, the increasing incidences of chronic diseases, such as hyperthyroidism, cancer, hypothyroidism, polycystic disease (PCOD), lupus, hypopituitarism, etc., are further augmenting the market growth. Moreover, the growing popularity of low-level laser therapy, a non-pharmacological and non-surgical viable therapeutic procedure for hair restoration that offers the convenience of at-home use and minimizes the need for clinical visits, is also catalyzing the global market.

Apart from this, the elevating requirement for off-label and over-the-counter medications and the high consumption of dietary supplements to prevent and control hair loss are expected to bolster the androgenetic alopecia market in the coming years.

What is included in the report segmentation?

The report covers the following aspects:

Report Period:

Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033

Countries Included:

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the androgenetic alopecia market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the androgenetic alopecia market
Reimbursement scenario in the market
In-market and pipeline drugs

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status

Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/request?type=report&id=6640&flag=C

How This Report Can Help You:

The report on androgenetic alopecia market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the androgenetic alopecia market.

The androgenetic alopecia market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.

Our report on the androgenetic alopecia market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.

Browse Our Latest Healthcare Research Report:

Ocular Hypertension Market Report 2023-2033: https://www.imarcgroup.com/ocular-hypertension-market

Recurrent Glioblastoma Market Report 2023-2033: https://www.imarcgroup.com/recurrent-glioblastoma-market

Uterine Fibroids Market Report 2023-2033: https://www.imarcgroup.com/uterine-fibroids-market

Optic Neuropathy Market Report 2023-2033: https://www.imarcgroup.com/optic-neuropathy-market

Key Questions Answered in this Report:

How has the androgenetic alopecia market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the androgenetic alopecia market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the androgenetic alopecia market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us: -

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.